blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3640261

EP3640261 - THERAPEUTIC AGENT FOR CHRONIC ARTHRITIDES DISEASES OF CHILDHOOD-RELATED DISEASES [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  25.08.2023
Database last updated on 24.07.2024
FormerRequest for examination was made
Status updated on  23.10.2020
FormerThe application has been published
Status updated on  20.03.2020
Most recent event   Tooltip25.08.2023Withdrawal of applicationpublished on 27.09.2023  [2023/39]
Applicant(s)For all designated states
Chugai Seiyaku Kabushiki Kaisha
5-1, Ukima 5-chome
Kita-ku
Tokyo 115-8543 / JP
[2020/17]
Inventor(s)01 / YOSHIZAKI, Kazuyuki
3-8-4, Midori-cho
Ashiya-shi
Hyogo 659-0042 / JP
02 / NISHIMOTO, Norihiro
4-6-9-804, Nyoidani
Minoo-shi
Osake 562-0011 / JP
03 / IWAMOTO, Masahiro
Utsukushigaoka 2-chome
Oyama-shi
Tochigi 329-0207 / JP
04 / MINOTO, Seiji
37-7-908
Minamisenju 6-chome
Arakawa-ku
Tokyo 116-0003 / JP
 [2020/17]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2020/17]
Application number, filing date19196253.902.04.2002
[2020/17]
Priority number, dateJP2001010362702.04.2001         Original published format: JP 2001103627
JP2001010913106.04.2001         Original published format: JP 2001109131
[2020/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3640261
Date:22.04.2020
Language:EN
[2020/17]
Search report(s)(Supplementary) European search report - dispatched on:EP24.03.2020
ClassificationIPC:C07K16/28, A61K45/00, A61K39/395, A61P19/02
[2020/17]
CPC:
C07K16/2866 (EP,US); A61K39/395 (KR); A61K39/3955 (US);
A61K45/06 (US); A61K9/0019 (US); A61P19/02 (EP);
A61P29/00 (EP); A61P37/02 (EP); A61P43/00 (EP);
C07K16/248 (EP,US); A61K2039/505 (EP,US); C07K2317/14 (US);
C07K2317/24 (EP,US); C07K2317/76 (US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2020/48]
Former [2020/17]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE,  TR 
Extension statesAL21.10.2020
LT21.10.2020
LV21.10.2020
MK21.10.2020
RO21.10.2020
SI21.10.2020
TitleGerman:THERAPEUTIKUM GEGEN CHRONISCHE ARTHRITIDEN VON KRANKHEITEN IM KINDESALTER[2020/17]
English:THERAPEUTIC AGENT FOR CHRONIC ARTHRITIDES DISEASES OF CHILDHOOD-RELATED DISEASES[2020/17]
French:AGENT THÉRAPEUTIQUE POUR ARTHRITES CHRONIQUES DE MALADIES INFANTILES[2020/17]
Examination procedure21.10.2020Examination requested  [2020/48]
21.10.2020Date on which the examining division has become responsible
12.11.2020Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
22.01.2021Amendment by applicant (claims and/or description)
22.08.2023Application withdrawn by applicant  [2023/39]
07.12.2023Date of oral proceedings
Parent application(s)   TooltipEP02708772.5  / EP1374900
EP10011862.9  / EP2298812
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
22.01.2021Request for further processing filed
22.01.2021Full payment received (date of receipt of payment)
Request granted
05.02.2021Decision despatched
Fees paidRenewal fee
09.09.2019Renewal fee patent year 03
09.09.2019Renewal fee patent year 04
09.09.2019Renewal fee patent year 05
09.09.2019Renewal fee patent year 06
09.09.2019Renewal fee patent year 07
09.09.2019Renewal fee patent year 08
09.09.2019Renewal fee patent year 09
09.09.2019Renewal fee patent year 10
09.09.2019Renewal fee patent year 11
09.09.2019Renewal fee patent year 12
09.09.2019Renewal fee patent year 13
09.09.2019Renewal fee patent year 14
09.09.2019Renewal fee patent year 15
09.09.2019Renewal fee patent year 16
09.09.2019Renewal fee patent year 17
09.09.2019Renewal fee patent year 18
26.03.2020Renewal fee patent year 19
26.04.2021Renewal fee patent year 20
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]EP0783893  (CHUGAI PHARMACEUTICAL CO LTD [JP], et al) [A] 1-26 * page 7, line 51 - page 8, line 15 *;
 [A]EP0983767  (CHUGAI PHARMACEUTICAL CO LTD [JP]) [A] 1-26 * column 24 - column 25 *;
 [I]  - DE BENEDETTI F ET AL, "Juvenile idiopathic arthritis: will etanercept be an improvement over current therapies?", BIODRUGS, ADIS INTERNATIONAL LTD, NZ, (20000801), vol. 14, no. 2, ISSN 1173-8804, pages 93 - 98, XP009190015 [I] 1-26 * page 93, column r, paragraph 2 * * page 96, column l, paragraph 2 * * page 97, column r, paragraph 2 *
 [YA]  - YOSHIZAKI K ET AL, "THERAPY OF RHEUMATOID ARTHRITIS BY BLOCKING IL-6 SIGNAL TRANSDUCTION WITH A HUMANIZED ANTI-IL-6 RECEPTOR ANTIBODY", SPRINGER SEMINARS IN IMMUNOPATHOLOGY, SPRINGER, BERLIN, DE, (1998), vol. 20, no. 1/2, ISSN 0172-6641, pages 247 - 259, XP001069950 [Y] 1-15 * abstract * * page 254, paragraph 3 - page 256, paragraph 2 * [A] 16-26
 [YA]  - MANGGE H ET AL, "Long-term follow-up of cytokines and soluble cytokine receptors in peripheral blood of patients with juvenile rheumatoid arthritis.", JOURNAL OF INTERFERON & CYTOKINE RESEARCH : THE OFFICIAL JOURNAL OF THE INTERNATIONAL SOCIETY FOR INTERFERON AND CYTOKINE RESEARCH SEP 1999, (199909), vol. 19, no. 9, ISSN 1079-9907, pages 1005 - 1010, XP009104085 [Y] 1-15 * page 1005, column l, paragraph 1 * * page 1009; table 1 * [A] 16-26

DOI:   http://dx.doi.org/10.1089/107999099313217
 [A]  - DE BENEDETTI F ET AL, "Is systemic juvenile rheumatoid arthritis an interleukin 6 mediated disease?", JOURNAL OF RHEUMATOLOGY, TORONTO, CA, (19980201), vol. 25, no. 2, ISSN 0315-162X, pages 203 - 207, XP009103922 [A] 1-26 * abstract * * page 205, column L, paragraph 2 - column R, paragraph 1 *
 [A]  - ARKACHAISRI T ET AL, "USE OF BIOLOGICS IN THE TREATMENT OF CHILDHOOD RHEUMATIC DISEASES", CURRENT RHEUMATOLOGY REPORTS, CURRENT SCIENCE, PHILADELPHIA, PA, US, (20000801), vol. 2, no. 4, ISSN 1523-3774, pages 330 - 336, XP009031120 [A] 1-26 * page 330, column R, paragraph 2 * * page 332, column R, paragraph 3 - page 333, column L, paragraph 2 *
 [A]  - YILMAZ M ET AL, "Cytokine levels in serum of patients with juvenile rheumatoid arthritis.", CLINICAL RHEUMATOLOGY 2001, (200101), vol. 20, no. 1, ISSN 0770-3198, pages 30 - 35, XP009104083 [A] 1-26 * page 34, column R, paragraph 2 - page 35, column L, paragraph 2 *

DOI:   http://dx.doi.org/10.1007/s100670170100
 [A]  - MANGGE HARALD ET AL, "Cytokines in juvenile rheumatoid arthritis (JRA)", CYTOKINE, (199806), vol. 10, no. 6, ISSN 1043-4666, pages 471 - 480, XP002281430 [A] 1-26 * section "Concluding remarks" last two paragraphs page 477 *

DOI:   http://dx.doi.org/10.1006/cyto.1997.0306
 [A]  - MIHARA M ET AL, "HUMINIZED ANTIBODY TO HUMAN INTERLEUKIN-6 RECEPTOR INHIBITS THE DEVELOPMENT OF COLLAGEN ARTHRITIS IN CYNOMOLGUS MONKEYS", CLINICAL IMMUNOLOGY, ACADEMIC PRESS,, US, (200103), vol. 98, no. 3, ISSN 1521-6616, pages 319 - 326, XP001069970 [A] 1-26 * abstract *

DOI:   http://dx.doi.org/10.1006/clim.2000.4989
 [A]  - SATO K ET AL, "Reshaping a human antibody to inhibit the interleukin 6 -dependent tumor cell growth", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER REREARCH, US, (19930215), vol. 53, ISSN 0008-5472, pages 851 - 856, XP002119558 [A] 1-26 * abstract *
 [A]  - DE BENEDETTI FABRIZIO ET AL, "Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I: A model for stunted growth in children with chronic inflammation", JOURNAL OF CLINICAL INVESTIGATION, (1997), vol. 99, no. 4, ISSN 0021-9738, pages 643 - 650, XP002281431 [A] 1-26 * abstract * * last three paragraphs of the Discussion section page 649 *

DOI:   http://dx.doi.org/10.1172/JCI119207
 [A]  - GALLAGHER K T ET AL, "JUVENILE RHEUMATOID ARTHRITIS", CURRENT OPINION IN RHEUMATOLOGY, CURRENT SCIENCE, LONDON, GB, (19990101), vol. 11, no. 5, ISSN 1040-8711, pages 372 - 376, XP009031046 [A] 1-26 * page 373, column L, paragraph 3 *

DOI:   http://dx.doi.org/10.1097/00002281-199909000-00008
 [A]  - KEUL R ET AL, "A possible role for soluble IL-6 receptor in the pathogenesis of systemic onset juvenile chronic arthritis.", CYTOKINE SEP 1998, (199809), vol. 10, no. 9, ISSN 1043-4666, pages 729 - 734, XP009104086 [A] 1-26 * abstract * * page 732, column R, paragraph 3 *

DOI:   http://dx.doi.org/10.1006/cyto.1997.0343
 [A]  - FISHMAN D ET AL, "THE EFFECT OF NOVEL POLYMORPHISMS IN THE INTERLEUKIN-6 (IL-6) GENE ON IL-6 TRANSCRIPTION AND PLASMA IL-6 LEVELS AND AN ASSOCIATION WITH SYSTEMIC-ONSET JUVENILE CHRONIC ARTHRITIS", JOURNAL OF CLINICAL INVESTIGATION, NEW YORK, NY, US, (19981001), ISSN 0021-9738, pages 1369 - 1376, XP002952078 [A] 1-26 * abstract *

DOI:   http://dx.doi.org/10.1172/JCI2629
 [A]  - ELLIOTT M J ET AL, "SUPPRESSION OF FEVER AND THE ACUTE-PHASE RESPONSE IN A PATIENT WITH JUVENILE CHRONIC ARTHRITIS TREATED WITH MONOCLONAL ANTIBODY TO TUMOUR NECROSIS FACTOR-ALPHA (CA2)", BRITISH JOURNAL OF RHEUMATOLOGY, OXFORD UNIVERSITY PRESS, GB, (19970101), vol. 36, doi:10.1093/RHEUMATOLOGY/36.5.589, ISSN 0263-7103, pages 589 - 593, XP002953580 [A] 1-26 * abstract *

DOI:   http://dx.doi.org/10.1093/rheumatology/36.5.589
 [A]  - ELLIOTT M J ET AL, "Treatment of systemic juvenile chronic arthritis (JCA) with monoclonal anti-TNF-alpha: Temporary control of systemic but not articular features of disease", ARTHRITIS AND RHEUMATISM, & 58TH NATIONAL SCIENTIFIC MEETING OF THE AMERICAN COLLEGE OF RHEUMATOLOGY AND THE 29TH NATIONAL SCIEN; MINNEAPOLIS, MINNESOTA, USA; OCTOBER 23-27, 1994, (1994), vol. 37, no. 9 SUPPL., ISSN 0004-3591, page S276, XP009109042 [A] 1-26 * abstract *
by applicantEP0125023
 EP0239400
 EP0325474
 JPH02188600
 EP0411946
 JPH03139293
 JPH03155795
 JPH03219894
 WO9201047
 WO9203918
 WO9219759
 WO9220791
 WO9306213
 US5210075
 US5216128
 WO9311236
 WO9312227
 WO9319172
 WO9402602
 FR2694767
 WO9411523
 WO9425585
 WO9501438
 WO9509873
 WO9515388
 JPH07324097
 WO9617869
 WO9618648
 WO9630394
 WO9634096
 WO9633735
 US5571513
 JPH08291199
 JPH08311098
    - HIRANO, T. et al., Nature, (19860000), vol. 324, pages 73 - 76
    - AKIRA, S. et al., Adv. in Immunology, (19930000), vol. 54, pages 1 - 78
    - LOTZ, M. et al., J. Exp. Med., (19880000), vol. 167, pages 1253 - 1258
    - TAGA T. et al., J. Exp. Med., (19870000), vol. 166, pages 967 - 981
    - YAMASAKI, K. et al., Science, (19870000), vol. 241, pages 825 - 828
    - TAGA et al., Cell, (19890000), vol. 58, pages 573 - 581
    - NOVICK D. et al., Hybridoma, (19910000), vol. 10, pages 137 - 146
    - HUANG, Y.W. et al., Hybridoma, (19930000), vol. 12, pages 621 - 630
    - HIRATA et al., "one of anti-IL-6 receptor antibodies", J. Immunology, (19890000), vol. 143, pages 2900 - 2906
    - FINK CW, "Proposal for the development of classification criteria for idiopathic arthritides of childhood", J. Rheumatol., (19950000), vol. 22, page 1566
    - SOUTHWOOD TR, "Classifying childhood arthritis", Ann. Rheum. Dis., (19970000), vol. 56, page 79
    - SHUNPEI YOKOTA, "Advances in recent therapeutic methods for chronic arthritides diseases of childhood", Rheumatism, (19990000), vol. 39, page 860
    - YAMAGUCHI, Journal of Rheumatology, (19920000), vol. 19, no. 3, pages 424 - 30
    - Seminars in Arthritis & Rheumatism, (19870000), vol. 17, no. 1, pages 39 - 57
    - GOLDMAN, Southern Medical Journal, (19800000), vol. 73, pages 555 - 563
    - Arthritis Rheum., (19910000), vol. 34, page 1158
    - J. Clin. Invest., (19940000), vol. 93, page 2114
    - Br. J. Rheumatol., (19950000), vol. 34, page 454
    - MATSUDA et al., Eur. J. Immunology, (19880000), vol. 18, pages 951 - 956
    - BIRD, R.E. et al., TI BTECH, (19910000), vol. 21, pages 132 - 137
    - Eur. J. Biochem., (19870000), vol. 168, pages 543 - 550
    - MATSUDA, T. et al., J. Immunol., (19880000), vol. 140, pages 1534 - 1541
    - Agr. Biol. Chem., (19900000), vol. 54, pages 2685 - 2688
    - TAMURA, T. et al., Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, pages 11924 - 11928
    - HIRATA, Y. et al., J. Immunology, (19890000), vol. 143, pages 2900 - 2906
    - YASUKAWA et al., Biochem., (19900000), vol. 108, pages 673 - 676
    - KEARNEY, J.F. et al., J. Immunol., (19790000), vol. 123, pages 1548 - 1550
    - Current Topics in Microbiology and Immunology, (19780000), vol. 81, pages 1 - 7
    - KOHLER, G.MILSTEIN, C., Eur. J. Immunol., (19760000), vol. 6, pages 511 - 519
    - MARGULIES, D.H. et al., Cell, (19760000), vol. 8, pages 405 - 415
    - SHULMAN, M. et al., Nature, (19780000), vol. 276, pages 269 - 270
    - DE ST. GROTH, S.F. et al., J. Immunol. Methods, (19800000), vol. 35, pages 1 - 21
    - TROWBRIDGE, I.S., J. Exp. Med., (19780000), vol. 148, pages 313 - 323
    - MULLIGAN, R.C. et al., Nature, (19790000), vol. 277, pages 108 - 114
    - KOHLER, G.MILSTEIN, C., Methods Enzymol., (19810000), vol. 73, pages 3 - 46
    - MIZUSHIMA, S.NAGATA, S., Nucleic Acids Res., (19900000), vol. 18, page 5322
    - CHIRGWIN, J.M. et al., Biochemistry, (19790000), vol. 18, pages 5294 - 5299
    - CHOMCZYNSKI, P. et al., Anal. Biochem., (19870000), vol. 162, pages 156 - 159
    - FROHMAN, M.A. et al., Proc. Natl. Acad. Sci. U.S.A., (19880000), vol. 85, pages 5879 - 5883
    - BELYAVSKY, A. et al., Nucleic Acids Res., (19890000), vol. 17, pages 2919 - 2932
    - SATO, K. et al., Cancer Res., (19930000), vol. 53, pages 851 - 856
    - WARD, E.S. et al., Nature, (19890000), vol. 341, pages 544 - 546
    - WARD, E.S. et al., FASEB J., (19920000), vol. 6, pages 2422 - 2427
    - BETTER, M. et al., Science, (19880000), vol. 241, pages 1041 - 1043
    - LEI, S.P. et al., J. Bacteriol., (19870000), vol. 169, pages 4379 - 4383
    - EBERT, K.M. et al., Bio/Technology, (19940000), vol. 12, pages 699 - 702
    - MAEDA, S. et al., Nature, (19850000), vol. 315, pages 592 - 594
    - JULIAN,K.-C. MA et al., Eur. J. Immunol., (19940000), vol. 24, pages 131 - 138
    - CO, M.S. et al., J. Immunol., (19940000), vol. 152, pages 2968 - 2976
    - PLUCKTRUN, A.SKERRA, A., Methods Enzymol., (19890000), vol. 178, pages 497 - 515
    - ROUSSEAUX, J. et al., Methods Enzymol., (19860000), vol. 121, pages 663 - 669
    - VRIEND et al., J. Mol. Graphics, vol. 8, no. 11990, pages 52 - 56
    - BRAKENHOFF et al., J. Biol. Chem., (19940000), vol. 269, pages 86 - 93
    - SAVIONO et al., EMBO J., (19940000), vol. 13, pages 1357 - 1367
    - SAITO, T. et al., J. Immunol., (19910000), vol. 147, pages 168 - 173
    - URLAUB, G. et al., Proc. Natl. Acad. Sci. USA, (19800000), vol. 77, pages 4216 - 4220
    - CHEN, C. et al., Mol. Cell. Biol., (19870000), vol. 7, pages 2745 - 2751
    - HIRANO et al., Immunol. Lett., (19880000), vol. 17, pages 41 - 45
    - HIRATA, Y. et al., J. Immunol., (19890000), vol. 143, pages 19080 - 2906
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.